Loading clinical trials...
Loading clinical trials...
A Phase II Study of 5-Fluorouracil, Bevacizumab (Avastin), and Radiation in the Preoperative or Adjuvant Treatment of Patients With Stage II / III Rectal Cancer
Conditions
Interventions
5-Fluorouracil
Bevacizumab
+3 more
Locations
14
United States
Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
Northeast Arkansas Clinic
Jonesboro, Arkansas, United States
Florida Cancer Specialists
Fort Myers, Florida, United States
Integrated Community Oncology Network
Jacksonville, Florida, United States
Watson Clinic Center for Cancer Care and Research
Lakeland, Florida, United States
Northeast Georgia Medical Center
Gainesville, Georgia, United States
Start Date
March 1, 2006
Primary Completion Date
April 1, 2009
Completion Date
February 1, 2012
Last Updated
December 10, 2021
NCT02600949
NCT07446322
NCT06204094
NCT05919264
NCT07541924
NCT07536113
Lead Sponsor
SCRI Development Innovations, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions